Plasma copper and ceruloplasmin in patients with alcoholic liver steatosis

Bratislava Medical Journal

Volumn 109, Issue 10, 2008, Pages 431-433

  Uhlikova, E ^a   Kupcova, V ^a   Szantova, M ^a   Turecky, L ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Alcohol liver disease; Ceruloplasmin; Ceruloplasmin oxidase activity; Copper; Fatty liver

Indexed keywords

APOCERULOPLASMIN; APOPROTEIN; CERULOPLASMIN; COPPER;

ADULT; AGED; ALCOHOLIC FATTY LIVER; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; APOPROTEINS; CERULOPLASMIN; COPPER; FATTY LIVER, ALCOHOLIC; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 62549090141     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bellentani S, Tiribelli C. Epidemiology and risk factors for fatty liver. In: Leuschner U, James O, Dancygier H (Eds). Steatohepatitis. Dordrecht, Kluwer Academic Publishers 2001, 374 p.
2. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8.
3. Kuntz E. Essentielle phospholipide in der hepatologie - 50 jahre experimentelle und klinische erfahrung. Z Gastroenterol 1991; Supppl (29): 7-13.
4. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt Biochem 1966; 15: 45-52.
5. Lieber CS. Pathogenesis and treatment of alcoholic liver disease. In: Lam SK, Paumgartner G, Wang B (Eds). Update on hepatobiliary diseases 1996. Dordrecht: Kluwer Academic Publishers, 1996: 69-84.
6. Malkin R, Malmstrom BG. The state and function of copper in biological systems. Adv Enzymol Relat Areas Mol Biol 1970; 33: 177-244.
7. Milne DB. Assessment of copper nutritional status. Clin Chem 1994; 39: 883-887.
8. Milne DB. Trace elements. In: Burtis CA, Ashwood ER (eds). Tietz textbook of clinical chemistry. Philadelphia: Saunders, 1999: 1029-1055.
9. Nomura F, Ohnishi K, Koen H, Hiyama Y, Nakayama T, Itoh Y, Shirai K, Saitoh Y, Okuda K. Serum cholinesterase in patients with fatty liver. J Clin Gastroenterol 1986; 8: 599-602.
10. Osaki S, Johnson DA, Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase. J Biol Chem 1971; 246: 3018-3023.
11. Přibyl T. Serum polyphenol oxidase activity (ceruloplasmin) in conventional laboratory animals and man. Folia biol (Praha) 1978; 24: 136-141.
12. Thomas L. Cholinesterases. In: Thomas L (ed). Labor und Diagnose. Frankfurt/Main: TH Books Verlagsgesellschaft mbH, 2000: 67-73.
13. Turecký L, Kupèová V, Mojto V, Smutný M, Uhlíková E, Vozár I. Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus. Bratisl Lek Listy 2005; 106: 266-269.
14. Wessling-Resnick M. Understanding copper uptake at the molecular level. Nutrition Rev 2002; 60: 177-186.